其他
免疫检查点抑制剂疗效评价:RECIST 1.1 or iRECIST?
1. Park H J , Kim G H , Kim K W , et al. Comparison ofRECIST 1.1 and iRECIST in Patients Treated with Immune Checkpoint Inhibitors: ASystematic Review and Meta-Analysis[J]. Cancers, 2021, 13(1):120.
2. Mulkey F , Theoret M R , Keegan P , et al.Comparison of iRECIST versus RECIST V.1.1 in patients treated with an anti-PD-1or PD-L1 antibody: pooled FDA analysis[J]. Journal for ImmunoTherapy of Cancer,2020, 8(1):e000146.
3. Patricia, Guyot, AE, et al. Enhanced secondaryanalysis of survival data: reconstructing the data from published Kaplan-Meiersurvival curves[J]. Bmc Medical Research Methodology, 2012, 12, 9.
精彩推荐:
- End -